In the age of Omicron variant: Paxlovid raises new hopes of COVID-19 recovery

J Med Virol. 2022 May;94(5):1766-1767. doi: 10.1002/jmv.27540. Epub 2021 Dec 29.

Authors

Zhonglei Wang^{1

2}, Liyan Yang³

Affiliations

¹ Key Laboratory of Green Natural Products and Pharmaceutical Intermediates in Colleges and Universities of Shandong Province, School of Chemistry and Chemical Engineering, Qufu Normal University, Qufu, China.
² School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
³ School of Physics and Physical Engineering, Qufu Normal University, Qufu, China.

PMID: 34936106
DOI: 10.1002/jmv.27540

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 Drug Treatment*
Drug Combinations
Humans
Lactams
Leucine
Nitriles
Proline
Ritonavir
SARS-CoV-2

Substances

Drug Combinations
Lactams
Nitriles
nirmatrelvir and ritonavir drug combination
Proline
Leucine
Ritonavir

Supplementary concepts

SARS-CoV-2 variants

Grants and funding

PhD research start-up fund (614901 and 615201)